Monoclonal antibodies in the treatment of myelogenous leukemias
- 1 January 1993
- book chapter
- Published by Springer Nature
- Vol. 64, 213-232
- https://doi.org/10.1007/978-1-4615-3086-2_11
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Current applications of monoclonal antibodies for the therapy of hematopoietic cancersCurrent Opinion in Immunology, 1991
- Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1990
- A humanized antibody that binds to the interleukin 2 receptor.Proceedings of the National Academy of Sciences, 1989
- Enhancement of monoclonal antibody dependent cell mediated cytotoxicity by IL2 and GM‐CSFBritish Journal of Haematology, 1989
- REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1HThe Lancet, 1988
- Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed.Journal of Clinical Investigation, 1987
- Heterogeneity of clonogenic cells in acute myeloblastic leukemia.Journal of Clinical Investigation, 1985
- A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cellsLeukemia Research, 1984
- Tumor Imaging with Radioactive Metal Chelates Conjugated to Monoclonal AntibodiesScience, 1982